Indefinite Delivery Contract 75N95022D00012

Award Date 6/1/22
Last Date to Order 5/31/25
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Dataconsult-Io LLC, a self-certified small disadvantaged business operating as Data Tecnica International. The 5-year, single-award IDIQ contract, valued up to $12,317,051.63, is for neurodegenerative disease scientific data analysis services in support of the NIA's Center for Alzheimer's and Related Dementias. The contract, which...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, an Indefinite Delivery Contract (IDC) valued at $149.2 million. The purpose of this contract is to provide manufacturing and nonclinical studies support for the development of therapeutic biotechnology products for neurological-related disorders. Under this IDC, NINDS...
The National Institutes of Health National Institute on Aging awarded a single award indefinite delivery contract to Life Molecular Imaging Limited with a potential value of $1,900,000. Task orders issued to date include $86,000 for tau protein positron emission tomography imaging services and $60,000 for amyloid doses. Both task orders are firm fixed price, for one-year periods of performance from September 2023 through September 2024. Life Molecular Imaging Limited will perform the work out of...
This indefinite delivery contract (IDC) was awarded by the National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, to Dataconsult-Io LLC, a self-certified small disadvantaged business operating as Data Tecnica International. The $18.6 million IDC, effective from August 2020 through August 2025, enables the NIA to issue multiple firm fixed-price delivery orders for neurodegenerative disease scientific data science and technology consulting services. Under this...
The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded an indefinite delivery contract (IDC) valued at up to $7,000,000 to 10X Genomics, Inc. to provide optimization slides, reagent kits, and reagent delivery methods to support research efforts into neurological diseases and disorders. As the prime contractor, 10X Genomics, a life sciences technology company, has delivered a range of specialized genomic analysis platforms,...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to PPD Development LP with a potential value of $545,452,906 to provide comprehensive and rapid response capabilities for research programs through September 2028. Task orders issued against the contract include over $132 million for clinical trial management support services relating to COVID-19, as well as orders valued at $2.33 million, $2 million, and $82.5...
The National Institute on Aging (NIA), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (DHHS), has awarded an Indefinite Delivery Contract (IDC) valued at $1,221,303.60 to Idexx Distribution, Inc. to provide pathology monitoring services for aged rodent colonies. This single-award IDC contract has a 5-year period of performance beginning March 1, 2025. The contractor will be responsible for receiving animals from the NIA's aged rodent...
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to The Emmes Company LLC on September 1, 2021. With a potential value of $545,452,906 over seven years, this single award IDC supports NIAID's research programs through a broad range of services. Task Order 1 issued under the contract is a firm fixed price order valued at $2,000 to satisfy minimum requirements. Performance will take place in Potomac, MD from September 1, 2021 through August 31,...
The National Institutes of Health (NIH) National Institute on Aging (NIA) has awarded a single-award Indefinite Delivery Contract (IDC) to Rose Li And Associates, Inc. (RLA), a certified economically disadvantaged women-owned small business, for science management and research administration support services. The $6.5 million IDC has a period of performance through August 2028. RLA has received several delivery orders against this IDC from NIA, including: a $33,810 fixed-price order for...
  • 75N95022D00012
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging (NIA) awarded a $2,326,159.08 Indefinite Delivery Contract (IDC) to the prime contractor QPS Austria GmbH, a for-profit contract research organization. The IDC, which has a period of performance through May 31, 2025, is to provide experimental validation of candidate Alzheimer's disease treatments identified through multi-omics analyses under the NIA's Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study. The contracted services involve testing these candidate treatments in transgenic Alzheimer's mouse models to determine their effects on disease pathology and progression. The contract does not have any set-aside designation and the work will be performed in Austria by the prime contractor.

Under the IDC, the NIA has awarded three firm fixed price delivery orders to QPS Austria GmbH to date, valued at $858,106.08, $830,053.00, and $638,000.00 respectively. These delivery orders cover the experimental validation work across different performance periods through May 2025. The IDC and associated task orders aim to advance the development of new Alzheimer's disease treatment options identified through the NIA's DREAM study, which utilizes multi-omics analyses to repurpose existing drugs.

Generated 12/3/24, 9:46 AM